+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Hysterectomy Alternatives Market: By Procedure Type, Hysteroscopy, Endometrial Ablation and Hormonal Treatments, By Type & By Region - Forecast 2016-2021

  • ID: 3920050
  • Report
  • 162 pages
  • IndustryARC
1 of 2
Hysterectomy is performed when a woman is suffering from conditions such as fibroids, uterine prolapse, endometriosis, chronic pelvic pain, vaginal bleeding and cancer of uterus among others. Depending on the severity of the condition the hysterectomy can be partial or complete which involves removal of uterus. Hysterectomy has various side-effects associated with it. These include hormonal imbalance, inability to conceive and disappearance of menstruation among others. To overcome these effects alternative methods are currently being adopted by the gynaecologist. These include myomectomy, uterine artery embolization, hysteroscopy, endometrial ablation and hormonal treatments.

Globally, rise in gynaecological problems in women is the major driver for alternative hysterectomy market. Inefficient treatment through hysterectomy would also drive the growth of this market as it leads to side effects such as hormonal imbalance, rise in infection rates and mood swings. However, lack of proper funding and government regulations may restrain the growth of the market during the forecast period.

This report identifies the global hysterectomy alternatives market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global hysterectomy alternatives market.

Geographically North America is estimated to dominate the global hysterectomy alternatives market, and is projected to have fastest growth, owing to higher accessibility and prevalence of gynaecological diseases. North America is estimated to be followed by Europe and Asia-Pacific. Non-Invasive procedures are estimated to witness a higher growth during the forecast period.

This report segments global Hysterectomy Alternatives market on the basis of procedure type, by type, and regional market as follows:

Global Hysterectomy Alternatives Market, by Procedure Type: Myomectomy, Uterine Artery Embolization (UAE), Hysteroscopy, Endometrial Ablation and Hormonal Treatments
Global Hysterectomy Alternatives Market, by Type: Invasive and Non-Invasive
This is report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region.

This report identifies all the major companies currently operating in the global Hysterectomy Alternatives market. Some of the major companies’ profiles in detail are as follows:

Conceptus Inc.

Ethicon Inc.

Hologic Inc.

Boston Scientific Corporation
Karl Storz GmbH & Co. Kg
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 2
1. Global Hysterectomy Alternatives Market – Market Overview

2. Executive Summary

3. Global Hysterectomy Alternatives Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis

4. Global Hysterectomy Alternatives Market– Market Forces
4.1. Drivers
4.1.1. Rise in Gynaecological Problems
4.2. Restraints
4.2.1. Lack of Proper Funding
4.3. Opportunities
4.3.1. Increased medical Access
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Global Hysterectomy Alternatives Market - By Procedure Type
5.1. Myomectomy
5.2. Uterine Artery Embolization (UAE)
5.3. Hysteroscopy
5.4. Endometrial Ablation
5.5. Hormonal Treatments

6. Global Hysterectomy Alternatives Market - By Type
6.1. Invasive
6.2. Non-Invasive

7. Global Hysterectomy Alternatives Market - By Geography (2014-2021)
7.1. Europe
7.1.1. Germany
7.1.2. France
7.1.3. Italy
7.1.4. Spain
7.1.5. Russia
7.1.6. U.K.
7.1.7. Rest of Europe
7.2. Asia Pacific
7.2.1. China
7.2.2. India
7.2.3. Japan
7.2.4. South Korea
7.2.5. Rest of Asia-Pacific
7.3. North America
7.3.1. U.S.
7.3.2. Canada
7.3.3. Mexico
7.4. Rest of the World (RoW)
7.4.1. Brazil
7.4.2. Rest of RoW

8. Global Hysterectomy Alternatives – Market Entropy
8.1. Expansion
8.2. Technological Developments
8.3. Merger & Acquisitions, and Joint Ventures
8.4. Supply- Contract

9. Company Profiles (Top 10 Companies)
9.1. Conceptus Inc.
9.1.1. Introduction
9.1.2. Financials
9.1.3. Key Insights
9.1.4. Key Strategy
9.1.5. Product Portfolio
9.1.6. SWOT Analysis
9.2. Ethicon Inc.
9.2.1. Introduction
9.2.2. Financials
9.2.3. Key Insights
9.2.4. Key Strategy
9.2.5. Product Portfolio
9.2.6. SWOT Analysis
9.3. Hologic Inc.
9.3.1. Introduction
9.3.2. Financials
9.3.3. Key Insights
9.3.4. Key Strategy
9.3.5. Product Portfolio
9.3.6. SWOT Analysis
9.4. Boston Scientific Corporation
9.4.1. Introduction
9.4.2. Financials
9.4.3. Key Insights
9.4.4. Key Strategy
9.4.5. Product Portfolio
9.4.6. SWOT Analysis
9.5. Karl Storz GmbH & Co. Kg
9.5.1. Introduction
9.5.2. Financials
9.5.3. Key Insights
9.5.4. Key Strategy
9.5.5. Product Portfolio
9.5.6. SWOT Analysis
9.6. Coopersurgical Inc.
9.6.1. Introduction
9.6.2. Financials
9.6.3. Key Insights
9.6.4. Key Strategy
9.6.5. Product Portfolio
9.6.6. SWOT Analysis
9.7. Gynecare
9.7.1. Introduction
9.7.2. Financials
9.7.3. Key Insights
9.7.4. Key Strategy
9.7.5. Product Portfolio
9.7.6. SWOT Analysis
9.8. American Medical Systems
9.8.1. Introduction
9.8.2. Financials
9.8.3. Key Insights
9.8.4. Key Strategy
9.8.5. Product Portfolio
9.8.6. SWOT Analysis
9.9. PlanMed
9.9.1. Introduction
9.9.2. Financials
9.9.3. Key Insights
9.9.4. Key Strategy
9.9.5. Product Portfolio
9.9.6. SWOT Analysis
9.10. Agfa
9.10.1. Introduction
9.10.2. Financials
9.10.3. Key Insights
9.10.4. Key Strategy
9.10.5. Product Portfolio
9.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

10. Appendix
10.1. Abbreviations
10.2. Sources
10.3. Research Methodology
10.4. Expert Insights
Note: Product cover images may vary from those shown
3 of 2